InsiderFlow

Gil M Labrucherie

NKTR

Gil M Labrucherie serves as Chief Financial Officer at Nektar Therapeutics (NKTR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$429.2K

Total Sells

5 trades

$762.3K

Net Position

Net Seller

$333.2K

Companies Traded

3

SEPN, NKTR, RZLT

Active Period

May 2021 – Feb 2025

8 total trades

Most Recent

Buy SEPN

Feb 27, 2025 · $56.9K

Gil M Labrucherie's Insider Trading at Nektar Therapeutics (NKTR)

Buys

0 · $0.00

Sells

5 · $762.3K

Total Shares Bought

0

Total Shares Sold

67,941

NKTR Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
May 17, 2022Sell17,448$3.95$68.9K312,905
Feb 18, 2022Sell7,579$10.95$83.0K301,603
Nov 18, 2021Sell24,149$13.10$316.4K259,682
Aug 18, 2021Sell10,867$13.76$149.5K243,231
May 19, 2021Sell7,898$18.30$144.5K251,098

Gil M Labrucherie's Insider Trading at Septerna, Inc. (SEPN)

Buys

2 · $229.2K

Sells

0 · $0.00

Total Shares Bought

40,000

Total Shares Sold

0

SEPN Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Feb 27, 2025Buy10,000$5.69$56.9K40,000
Feb 21, 2025Buy30,000$5.74$172.3K30,000

Gil M Labrucherie's Insider Trading at Rezolute, Inc. (RZLT)

Buys

1 · $200.0K

Sells

0 · $0.00

Total Shares Bought

52,631

Total Shares Sold

0

RZLT Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
May 6, 2022Buy52,631$3.80$200.0K52,631